Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 13/05/2008

    A new method unmasks noroviruses on food

    Noroviruses often might be the causative agents of Nausea vomiting diarrhoea fever. The Chemical and Veterinary Investigation Office in Stuttgart has now developed a method that enables the detection of these viruses on food.

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-new-method-unmasks-noroviruses-on-food
  • Article - 13/05/2008 17654_de.jpg

    The bachelor's degree as seen by companies: jump start or pole position?

    The number of bachelors degree graduates in Germany is still low and companies do not yet have much experience of the new degrees. However one thing has already become clear A bachelors degree is not sufficient for all professional fields. Those hoping for a future in research must continue their university education beyond the initial six semesters.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-bachelor-s-degree-as-seen-by-companies-jump-start-or-pole-position
  • Article - 11/05/2008

    Market report on antioxidants published

    In an independent market study by Ceresana Research the latest data facts and trends of the antioxidant market are analysed and presented. Data concerning the antioxidant market are subdivided by region based on value and quantity.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/market-report-on-antioxidants-published
  • Press release - 07/05/2008

    Confidence with restrictions

    In their 9th German Biotechnology Report the industry experts from Ernst Young paint an essentially confident picture of the German biotech industry. However despite the general optimism the picture has a few negative points no company will go public in 2008.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/confidence-with-restrictions
  • Article - 06/05/2008

    Vetter clients can concentrate fully on their core business

    The Ravensburg-based company Vetter Pharma-Fertigung GmbH & Co. KG is one of the leaders in biopharmaceutical contract manufacturing. We spoke with Max Horn, who has been with the company since 1981 and was appointed Managing Director in 2002.

    https://www.gesundheitsindustrie-bw.de/en/article/news/vetter-clients-can-concentrate-fully-on-their-core-business
  • Article - 04/05/2008 Many people accepted the IBST

    Better qualifications pay off

    At the beginning of October 2008 the MBA course on Medical Devices and Healthcare Management will commence at the INTERNATIONAL BUSINESS SCHOOL TUTTLINGEN IBST. This masters course an extra-occupational two-year distance-learning course with attendance phases.

    https://www.gesundheitsindustrie-bw.de/en/article/news/better-qualifications-pay-off
  • Article - 03/05/2008

    Immatics started second proof-of-concept study

    Immatics biotechnologies GmbH announced the start of a Phase III trial of its IMA910 cancer vaccine in patients with advanced colorectal cancer. The study will enroll about 70 patients in 8 European countries. The vaccine is developed to slow or halt tumor progression.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/immatics-started-second-proof-of-concept-study
  • Press release - 03/05/2008

    New course in biostatistics

    From the winter term 20082009 Ulm University will offer a new bachelor course in mathematical biometry. The course which is unique in Germany provides basic knowledge in applied mathematics computer science and the life sciences.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-course-in-biostatistics
  • Article - 01/05/2008

    Peter Öhlschläger - New strategies for the treatment of cancer

    Professor Peter Öhlschläger established his major scientific interests very early on. During his degree thesis at the German Cancer Research Centre DKFZ in Heidelberg the immunologist succeeded in combining his two major interests namely virology and cancer. Öhlschläger is now junior professor at the University of Constance and mainly deals with the development of therapeutic cancer vaccines.

    https://www.gesundheitsindustrie-bw.de/en/article/news/peter-hlschlaeger-new-strategies-for-the-treatment-of-cancer
  • Press release - 28/04/2008

    Rentschler: experts in contract manufacturing

    The company Rentschler from Laupheim in the south of Germany is nowadays one of the biggest biopharmaceutical contract manufacturers in Europe. This has not always been the case. A look at the companys history shows why the company which is nowadays run by the third family generation has become what it is today.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/rentschler-experts-in-contract-manufacturing
  • Press release - 21/04/2008

    "Teaching does not come off badly"

    Since autumn 2007 Constance has been one of Germanys Elite Universities. UNI-ZEITUNG spoke with Prof. Dr. Andreas Marx spokesperson for the Department of Chemistry and head of the winning Chemical Biology graduate school about the practical consequences.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/teaching-does-not-come-off-badly
  • Article - 21/04/2008

    Human blood system in mice

    Scientists from Mannheim Heidelberg an Freiburg working together in the cooperative research area Vascular Biology have developed a method that can be used to create a human vascular system in mice which stays functional even after several months.

    https://www.gesundheitsindustrie-bw.de/en/article/news/human-blood-system-in-mice
  • Article - 21/04/2008

    Kilian Hennes - unusual ideas and a pragmatic approach

    People with know-how must bear responsibility said the microbiologist Dr. Kilian Hennes who lectures bioprocess engineering at Constance University of Applied Sciences HTWG. Teaching is one of the major challenges for the experienced scientist and practitioner in particular because his discipline is seen as somewhat exotic by future process engineers and requires a different way of looking at things. But this is what makes his job truly…

    https://www.gesundheitsindustrie-bw.de/en/article/news/kilian-hennes-unusual-ideas-and-a-pragmatic-approach
  • Press release - 20/04/2008

    New healthcare training and education options

    Baden-Württemberg universities have adapted their healthcare training and education to different requirements and a number of different specialised courses are on offer.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-healthcare-training-and-education-options
  • Article - 16/04/2008

    Roland Schuele - "Research cannot be predicted"

    Professor Roland Schuele from the University Womens Hospital in Freiburg originally studied biochemistry. Nowadays Schuele is researching the development of prostate cancer. During his scientific career he has learnt that research cannot be steered in a particular direction. It develops and we follow it said Schuele who has been able to gain astonishing insights into the molecular processes in tumour cells.

    https://www.gesundheitsindustrie-bw.de/en/article/news/roland-schuele-research-cannot-be-predicted
  • Press release - 16/04/2008

    Effective Cancer Immune Therapy Through Order in the Blood Vessels

    Researchers at the German Cancer Research Center have discovered a key molecule that is responsible for the immature structure of blood vessels in malignant tumors. If this molecule is switched off in mice vessels normalize so that immune cells are better able to get to the tumor tissue.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/effective-cancer-immune-therapy-through-order-in-the-blood-vessels
  • Press release - 08/04/2008

    Boehringer Ingelheim continues to grow

    Boehringer Ingelheim enjoyed continued success in 2007 and its growth is outpacing the pharmaceuticals market for the eighth year in a row. The companys turnover rose by 8.8 in local currency to almost EUR 11 billion.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/boehringer-ingelheim-continues-to-grow
  • Article - 05/04/2008

    Successful cooperation between science and industry (II)

    In the second article in the series on the platforms successful cooperations BioValley presents an encouraging approach for improving the quality of life of severely ill cancer patients and the successful establishment of an industrial biochip platform.

    https://www.gesundheitsindustrie-bw.de/en/article/news/successful-cooperation-between-science-and-industry-ii
  • Article - 31/03/2008

    "Nanomedicine will be able to combat incurable diseases"

    The first European Conference for Clinical Nanomedicine is to be held soon in Basel. BIOPRO has therefore discussed this promising area of application with Beat Löffler and Dr. Patrick Hunziker the founders of the European Foundation for Clinical Nanomedicine.

    https://www.gesundheitsindustrie-bw.de/en/article/news/nanomedicine-will-be-able-to-combat-incurable-diseases
  • Article - 29/03/2008

    Doctor’s rounds with virtual patients

    The medical online learning programme by the Tübingen-based E-learning publisher INMEDEA GmbH simulates procedures and situations in different departments of a hospital with their respective typical patient groups.

    https://www.gesundheitsindustrie-bw.de/en/article/news/doctor-s-rounds-with-virtual-patients
  • Article - 29/03/2008

    Freiburg researchers discover new effect of insulin

    Working with colleagues from the Harvard Medical School in Boston USA researchers from Freiburg University have discovered a previously unknown role of insulin in ageing and lifespan. Insulin inhibits a master stress regulator protein known as SKN-1.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/freiburg-researchers-discover-new-effect-of-insulin
  • Article - 29/03/2008

    Artificial micro RNAs in plant breeding

    Scientists from the Max Planck Institute for Developmental Biology in Tübingen and their colleagues from the International Rice Research Institute in the Philippines succeeded in accelerating rice plant breeding by using artificial small RNA molecules.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/artificial-micro-rnas-in-plant-breeding
  • Article - 20/03/2008

    The effect of migration from Africa on genetic diversity in Europe

    The paper by Lohmueller et al. 2008 shows that there is proportionally more deleterious genetic variation in European than in African populations. This revelation enables conclusions to be made on the group that emigrated from Africa several thousand years ago.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-effect-of-migration-from-africa-on-genetic-diversity-in-europe
  • Article - 16/03/2008 Logo apogenix

    New indication for lead compound of Apogenix

    Isolated tumour cells use to invade healthy brain tissue during the development and growth of glioblastoma multiforme GBM. This mechanism involves the CD95CD95L death system. These results supports the therapeutic potential of Apogenix APG101 for the treatment of glioblastomas.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-indication-for-lead-compound-of-apogenix
  • Article - 14/03/2008

    Elisa Izaurralde, a prominent RNA scientist, receives Leibniz Prize

    The directors of the Tübingen Max Planck Institute MPI for Developmental Biology are pleased to have a Leibniz prizewinner in their ranks for the second year running. Dr. Elisa Izaurralde and her colleague Dr. Elena Conti have both been awarded the 2008 prize for their outstanding work in the field of RNA research.

    https://www.gesundheitsindustrie-bw.de/en/article/news/elisa-izaurralde-a-prominent-rna-scientist-receives-leibniz-prize

Page 39 / 41

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search